Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sathapana Naorat is active.

Publication


Featured researches published by Sathapana Naorat.


Clinical Infectious Diseases | 2009

Incidence of Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand

Henry C. Baggett; Leonard F. Peruski; Sonja J. Olsen; Somsak Thamthitiwat; Julia Rhodes; Surang Dejsirilert; Wanna Wongjindanon; Scott F. Dowell; Julie Fischer; Peera Areerat; Denchai Sornkij; Possawat Jorakate; Anek Kaewpan; Prabda Prapasiri; Sathapana Naorat; Leelawadee Sangsuk; Boonchuay Eampokalap; Matthew R. Moore; Gloria Carvalho; Bernard Beall; Kumnuan Ungchusak; Susan A. Maloney

BACKGROUND Population-based estimates of the incidence of invasive pneumococcal disease are unavailable for Thailand and other countries in Southeast Asia. We estimated the incidence of pneumococcal bacteremia cases requiring hospitalization in rural Thailand. METHODS Blood cultures were performed on samples from hospitalized patients in 2 rural provinces where active, population-based surveillance of community-acquired pneumonia is conducted. Blood cultures were performed at clinician discretion and were encouraged for all patients with suspected pneumonia and all children aged <5 years with suspected sepsis. Pneumococcal antigen testing was performed on positive blood culture specimens that failed to grow organisms on subculture. RESULTS From May 2005 through June 2007, 23,853 blood culture specimens were collected overall, and 7319 were collected from children aged <5 years, which represented 66% and 47% of target patients, respectively. A total of 72 culture-confirmed pneumococcal bacteremia cases requiring hospitalization were identified. An additional 44 patients had media from positive blood cultures that yielded no growth on subculture but that had positive results of pneumococcal antigen testing. Of the 116 confirmed cases of bacteremia, 27 (23%) occurred in children aged <5 years; of these, 9 (33%) were confirmed by antigen testing only. The incidence of pneumococcal bacteremia cases requiring hospitalization among children aged <5 years had a range of 10.6-28.9 cases per 100,000 persons (incidence range if cases detected by antigen are excluded, 7.5-14.0 cases per 100,000 persons). CONCLUSIONS Invasive pneumococcal disease is more common than was previously suspected in Thailand, even on the basis of estimates limited to hospitalized cases of bacteremia. These estimates, which are close to estimates of the incidence of hospitalized cases of pneumococcal bacteremia in the United States before introduction of pneumococcal conjugate vaccine, provide important data to guide public health care policy and to inform discussions about vaccine introduction in Thailand and the rest of Southeast Asia.


Clinical Infectious Diseases | 2012

High Prevalence of Cryptococcal Infection Among HIV-Infected Patients Hospitalized With Pneumonia in Thailand

Julie R. Harris; Mark D. Lindsley; Sununta Henchaichon; Natteewan Poonwan; Sathapana Naorat; Prabda Prapasiri; Somrak Chantra; Fuangrak Ruamcharoen; Loretta S. Chang; Malinee Chittaganpitch; Nanthawan Mehta; Leonard F. Peruski; Susan A. Maloney; Benjamin J. Park; Henry C. Baggett

Cryptococcal antigenemia was common among human immunodeficiency virus-infected patients hospitalized with acute respiratory illness in Thailand. Few clinical differences were evident between antigenemic and nonantigenemic HIV-infected patients. Cryptococcal infection was a possible etiologic agent of pulmonary disease in many antigenemic patients.


Pediatric Infectious Disease Journal | 2014

Incidence and Etiology of Acute Lower Respiratory Tract Infections in Hospitalized Children Younger Than 5 Years in Rural Thailand

Reem Hasan; Julia Rhodes; Somsak Thamthitiwat; Sonja J. Olsen; Prabda Prapasiri; Sathapana Naorat; Malinee Chittaganpitch; Sununta Henchaichon; Surang Dejsirilert; Prasong Srisaengchai; Pongpun Sawatwong; Possawat Jorakate; Anek Kaewpwan; Alicia M. Fry; Dean D. Erdman; Somchai Chuananon; Tussanee Amornintapichet; Susan A. Maloney; Henry C. Baggett

Background: Pneumonia remains a leading cause of under-five morbidity and mortality globally. Comprehensive incidence, epidemiologic and etiologic data are needed to update prevention and control strategies. Methods: We conducted active, population-based surveillance for hospitalized cases of acute lower respiratory tract infections (ALRI) among children <5 years of age in rural Thailand. ALRI cases were systematically sampled for an etiology study that tested nasopharyngeal specimens by polymerase chain reaction; children without ALRI were enrolled as controls from outpatient clinics. Results: We identified 28,543 hospitalized ALRI cases from 2005 to 2010. Among the 49% with chest radiographs, 63% had findings consistent with pneumonia as identified by 2 study radiologists. The hospitalized ALRI incidence rate was 5772 per 100,000 child-years (95% confidence interval: 5707, 5837) and was higher in boys versus girls (incidence rate ratio 1.38, 95% confidence interval: 1.35–1.41) and in children 6–23 months of age versus other age groups (incidence rate ratio 1.76, 95% confidence interval: 1.69–1.84). Viruses most commonly detected in ALRI cases were respiratory syncytial virus (19.5%), rhinoviruses (18.7%), bocavirus (12.8%) and influenza viruses (8%). Compared with controls, ALRI cases were more likely to test positive for respiratory syncytial virus, influenza, adenovirus, human metapneumovirus and parainfluenza viruses 1 and 3 (P ⩽ 0.01 for all). Bloodstream infections, most commonly Streptococcus pneumoniae and nontyphoidal Salmonella, accounted for 1.8% of cases. Conclusions: Our findings underscore the high burden of hospitalization for ALRI and the importance of viral pathogens among children in Thailand. Interventions targeting viral pathogens coupled with improved diagnostic approaches, especially for bacteria, are critical for better understanding of ALRI etiology, prevention and control.


The Journal of Infectious Diseases | 2013

Hospitalizations for Acute Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Thailand, 2008–2011

Sathapana Naorat; Malinee Chittaganpitch; Somsak Thamthitiwat; Sununta Henchaichon; Pongpun Sawatwong; Prasong Srisaengchai; Ying Lu; Somchai Chuananon; Tussanee Amornintapichet; Somrak Chantra; Dean D. Erdman; Susan A. Maloney; Passakorn Akarasewi; Henry C. Baggett

BACKGROUND Few population-based estimates of the incidence of respiratory syncytial virus (RSV) infection in low- or middle-income countries are available. We describe the incidence and epidemiology of hospitalizations for RSV-associated acute lower respiratory tract infection (ALRI) detected by active population-based surveillance in 2 rural Thailand provinces during 2008-2011. METHODS Patients hospitalized with ALRI were systematically sampled. Consenting patients provided nasopharyngeal swab specimens for RSV testing by real-time reverse-transcription polymerase chain reaction. RESULTS Of 13 982 enrolled patients hospitalized with ALRI, 1137 (8.1%) were RSV positive. After adjustment for sampling and nonenrollment, the incidence of RSV-associated ALRI hospitalization was 85 cases per 100,000 persons/year. The highest rates occurred among children aged <5 years (981 cases per 100,000 persons/year) and <1 year (1543 cases per 100,000 persons/year). Rates were low among older children and young adults but high among persons aged >65 years (130 cases per 100,000 persons/year). Eight (0.7%) RSV-infected study patients died during hospitalization. Annual RSV hospitalizations peaked during July-October with almost no documented RSV hospitalizations during January-June. CONCLUSIONS Our findings demonstrate the substantial contribution of RSV to global ALRI burden, especially in children aged <5 years and the elderly, and underscore the urgent need for effective prevention measures.


PLOS ONE | 2012

Incidence and Epidemiology of Hospitalized Influenza Cases in Rural Thailand during the Influenza A (H1N1)pdm09 Pandemic, 2009–2010

Henry C. Baggett; Malinee Chittaganpitch; Somsak Thamthitiwat; Prabda Prapasiri; Sathapana Naorat; Pongpun Sawatwong; Darunee Ditsungnoen; Sonja J. Olsen; James M. Simmerman; Prasong Srisaengchai; Somrak Chantra; Leonard F. Peruski; Pathom Sawanpanyalert; Susan A. Maloney; Pasakorn Akarasewi

Background Data on the burden of the 2009 influenza pandemic in Asia are limited. Influenza A(H1N1)pdm09 was first reported in Thailand in May 2009. We assessed incidence and epidemiology of influenza-associated hospitalizations during 2009–2010. Methods We conducted active, population-based surveillance for hospitalized cases of acute lower respiratory infection (ALRI) in all 20 hospitals in two rural provinces. ALRI patients were sampled 1∶2 for participation in an etiology study in which nasopharyngeal swabs were collected for influenza virus testing by PCR. Results Of 7,207 patients tested, 902 (12.5%) were influenza-positive, including 190 (7.8%) of 2,436 children aged <5 years; 86% were influenza A virus (46% A(H1N1)pdm09, 30% H3N2, 6.5% H1N1, 3.5% not subtyped) and 13% were influenza B virus. Cases of influenza A(H1N1)pdm09 first peaked in August 2009 when 17% of tested patients were positive. Subsequent peaks during 2009 and 2010 represented a mix of influenza A(H1N1)pdm09, H3N2, and influenza B viruses. The estimated annual incidence of hospitalized influenza cases was 136 per 100,000, highest in ages <5 years (477 per 100,000) and >75 years (407 per 100,000). The incidence of influenza A(H1N1)pdm09 was 62 per 100,000 (214 per 100,000 in children <5 years). Eleven influenza-infected patients required mechanical ventilation, and four patients died, all adults with influenza A(H1N1)pdm09 (1) or H3N2 (3). Conclusions Influenza-associated hospitalization rates in Thailand during 2009–10 were substantial and exceeded rates described in western countries. Influenza A(H1N1)pdm09 predominated, but H3N2 also caused notable morbidity. Expanded influenza vaccination coverage could have considerable public health impact, especially in young children.


Clinical Infectious Diseases | 2017

Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study

Nicholas Fancourt; Maria Deloria Knoll; Henry C. Baggett; W. Abdullah Brooks; Daniel R. Feikin; Laura L. Hammitt; Stephen R. C. Howie; Karen L. Kotloff; Orin S. Levine; Shabir A. Madhi; David R. Murdoch; J. Anthony G. Scott; Donald M. Thea; Juliet O. Awori; Breanna Barger-Kamate; James Chipeta; Andrea N. DeLuca; Mahamadou Diallo; Amanda J. Driscoll; Bernard E. Ebruke; Melissa M. Higdon; Yasmin Jahan; Ruth A. Karron; Nasreen Mahomed; David P. Moore; Kamrun Nahar; Sathapana Naorat; Micah Silaba Ominde; Daniel E. Park; Christine Prosperi

Summary In the Pneumonia Etiology Research for Child Health study, abnormal chest radiographs (CXRs) in cases were associated with hypoxemia, crackles, tachypnea, and fever. Overall, 54% of CXRs were abnormal (site range, 35%–64%). Consolidation on CXR was associated with an increased risk of mortality.


American Journal of Tropical Medicine and Hygiene | 2011

Incidence of Bacteremic Melioidosis in Eastern and Northeastern Thailand

Saithip Bhengsri; Henry C. Baggett; Possawat Jorakate; Anek Kaewpan; Prabda Prapasiri; Sathapana Naorat; Somsak Thamthitiwat; Kittisak Tanwisaid; Somrak Chantra; Prasert Salika; Surang Dejsirilert; Leonard F. Peruski; Susan A. Maloney

Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in northeastern Thailand. Population-based disease burden estimates are lacking and limited data on melioidosis exist from other regions of the country. Using active, population-based surveillance, we measured the incidence of bacteremic melioidosis in the provinces of Sa Kaeo (eastern Thailand) and Nakhon Phanom (northeastern Thailand) during 2006-2008. The average annual incidence in Sa Kaeo and Nakhon Phanom per 100,000 persons was 4.9 (95% confidence interval [CI] = 3.9-6.1) and 14.9 (95% CI = 13.3-16.6). The respective population mortality rates were 1.9 (95% CI = 1.3-2.8) and 4.4 (95% CI = 3.6-5.3) per 100,000. The case-fatality proportion was 36% among those with known outcome. Our findings document a high incidence and case fatality proportion of bacteremic melioidosis in Thailand, including a region not traditionally considered highly endemic, and have potential implications for clinical management and health policy.


Influenza and Other Respiratory Viruses | 2013

Hospitalization due to human parainfluenza virus–associated lower respiratory tract illness in rural Thailand

Oliver Morgan; Malinee Chittaganpitch; Birgit Clague; Somrak Chantra; Wichai Sanasuttipun; Prabda Prapasiri; Sathapana Naorat; Yongjua Laosirithavorn; Teresa C. T. Peret; Dean D. Erdman; Henry C. Baggett; Sonja J. Olsen; Alicia M. Fry

Background  Human parainfluenza viruses (HPIVs) are an important cause of acute respiratory illness in young children but little is known about their epidemiology in the tropics.


PLOS ONE | 2013

Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand: An Update on Incidence, Clinical Characteristics, Serotype Distribution, and Antimicrobial Susceptibility, 2005–2010

Julia Rhodes; Surang Dejsirilert; Susan A. Maloney; Possawat Jorakate; Anek Kaewpan; Prasert Salika; Thantapat Akarachotpong; Prabda Prapasiri; Sathapana Naorat; Peera Areerat; Asadang Ruayajin; Pathom Sawanpanyalert; Pasakorn Akarasewi; Leonard F. Peruski; Henry C. Baggett

Background Streptococcus pneumoniae is an important cause of morbidity and mortality in Southeast Asia, but regional data is limited. Updated burden estimates are critical as pneumococcal conjugate vaccine (PCV) is highly effective, but not yet included in the Expanded Program on Immunization of Thailand or neighboring countries. Methods We implemented automated blood culture systems in two rural Thailand provinces as part of population-based surveillance for bacteremia. Blood cultures were collected from hospitalized patients as clinically indicated. Results From May 2005– March 2010, 196 cases of pneumococcal bacteremia were confirmed in hospitalized patients. Of these, 57% had clinical pneumonia, 20% required mechanical ventilation, and 23% (n = 46) died. Antibiotic use before blood culture was confirmed in 25% of those with blood culture. Annual incidence of hospitalized pneumococcal bacteremia was 3.6 per 100,000 person-years; rates were higher among children aged <5 years at 11.7 and adults ≥65 years at 14.2, and highest among infants <1 year at 33.8. The median monthly case count was higher during December–March compared to the rest of the year 6.0 vs. 1.0 (p<0.001). The most common serotypes were 23F (16%) and 14 (14%); 61% (74% in patients <5 years) were serotypes in the 10-valent PCV (PCV 10) and 82% (92% in <5 years) in PCV 13. All isolates were sensitive to penicillin, but non-susceptibility was high for co-trimoxazole (57%), erythromycin (30%), and clindamycin (20%). Conclusions We demonstrated a high pneumococcal bacteremia burden, yet underestimated incidence because we captured only hospitalized cases, and because pre-culture antibiotics were frequently used. Our findings together with prior research indicate that PCV would likely have high serotype coverage in Thailand. These findings will complement ongoing cost effectiveness analyses and support vaccine policy evaluation in Thailand and the region.


American Journal of Tropical Medicine and Hygiene | 2015

Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006-2011: Implications for Pneumococcal Vaccine Considerations.

Barameht Piralam; Sara M. Tomczyk; Julia Rhodes; Somsak Thamthitiwat; Christopher J. Gregory; Sonja J. Olsen; Prabda Praphasiri; Pongpun Sawatwong; Sathapana Naorat; Somrak Chantra; Peera Areerat; Cameron P. Hurst; Matthew R. Moore; Charung Muangchana; Henry C. Baggett

The incidence of pneumococcal pneumonia among adults is a key driver for the cost-effectiveness of pneumococcal conjugate vaccine used among children. We sought to obtain more accurate incidence estimates among adults by including results of pneumococcal urine antigen testing (UAT) from population-based pneumonia surveillance in two Thai provinces. Active surveillance from 2006 to 2011 identified acute lower respiratory infection (ALRI)–related hospital admissions. Adult cases of pneumococcal pneumonia were defined as hospitalized ALRI patients aged ≥ 18 years with isolation of Streptococcus pneumoniae from blood or with positive UAT. Among 39,525 adult ALRI patients, we identified 481 pneumococcal pneumonia cases (105 by blood culture, 376 by UAT only). Estimated incidence of pneumococcal pneumonia hospitalizations was 30.5 cases per 100,000 persons per year (2.2 and 28.3 cases per 100,000 persons per year by blood culture and UAT, respectively). Incidence varied between 22.7 in 2007 and 43.5 in 2010, and increased with age to over 150 per 100,000 persons per year among persons aged ≥ 70 years. Viral coinfections including influenza A/B, respiratory syncytial virus (RSV), and adenovirus occurred in 11% (44/409) of pneumococcal pneumonia cases tested. Use of UAT to identify cases of pneumococcal pneumonia among adults in rural Thailand substantially increases estimates of pneumococcal pneumonia burden, thereby informing cost-effectiveness analyses and vaccine policy decisions.

Collaboration


Dive into the Sathapana Naorat's collaboration.

Top Co-Authors

Avatar

Henry C. Baggett

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Prabda Prapasiri

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Susan A. Maloney

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Leonard F. Peruski

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Possawat Jorakate

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Somrak Chantra

Thailand Ministry of Public Health

View shared research outputs
Top Co-Authors

Avatar

Julia Rhodes

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sonja J. Olsen

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Surang Dejsirilert

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Malinee Chittaganpitch

Thailand Ministry of Public Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge